RESUMEN
OBJECTIVE: Emotions play an important role in consumers' perception of a sensory experience. The objective of this work was to investigate the ability of basic skin care formulas (i.e. without interference of odour, colour and packaging) and pillar ingredients (i.e. emollients and rheology modifiers) to elicit emotions. Another objective was to track, as claimed by neurocosmetics, the possible effect of formulas to trigger emotions from their direct biochemical effects on the skin. METHODS: Standard methodologies were mobilized, combining subjective and behavioural parameters (i.e. verbatim, prosody and gesture). Sense and Story methodology based on a collection of metaphoric verbatim was conducted after an induction phase. In addition, an experimental electrophysiological real-time visualization method was tried as a first experience in cosmetics. Finally, the ability of formulations with emotional benefits to modulate the release of neuropeptides by sensory neurons was evaluated on a 3D human model (epidermis co-cultured with sensory neurons). RESULTS: Skin care formulas were shown to play a role in emotional potential and the types of emotion generated, while changing one ingredient mostly acted on the intensity of the emotions. Verbatim provided contrasted answers depending on the protocol, highlighting the interest of non-verbal approaches to detect subtle effects. The in vitro model substantiated physiological effects of skin care formulas with emotional potential on human skin sensory neuron activity. CONCLUSION: Emotions were impacted by the change in ingredients and were better captured through non-verbal methods.
OBJECTIF: Les émotions jouent un rôle important dans la perception qu'ont les consommateurs d'une expérience sensorielle. L'objectif de ce travail était d'étudier la capacité de formules de soins pour la peau de base (c'estàdire sans interférence d'odeur, de couleur, d'emballage) et d' ingrédients essentiels (c'estàdire les émollients et les modificateurs de rhéologie) à susciter des émotions. Un autre objectif était de suivre, comme le prétendent les neurocosmétiques, l'effet possible des formules à déclencher des émotions à partir de leurs effets biochimiques directs sur la peau. MÉTHODES: Des méthodologies standards ont été mises en Åuvre, combinant des paramètres subjectifs et comportementaux (c'estàdire verbatim, prosodie et gestuelle). La méthodologie Sense & Story basée sur un ensemble de verbatim métaphoriques a été mise en Åuvre après une phase d'induction. En outre, une méthode expérimentale de visualisation électrophysiologique en temps réel a été testée comme première expérience dans le domaine des cosmétiques. Enfin, la capacité des formulations présentant des bénéfices émotionnels à moduler la libération de neuropeptides par les neurones sensoriels a été évaluée sur un modèle humain 3D (épiderme cocultivé avec des neurones sensoriels). RÉSULTATS: Il a été démontré que les formules de soins pour la peau jouent un rôle dans le potentiel émotionnel et les types d'émotions générées, tandis que le changement d'un ingrédient agit principalement sur l'intensité des émotions. Le verbatim a fourni des réponses contrastées selon le protocole, soulignant l'intérêt des approches non verbales pour détecter les effets subtils. Le modèle in vitro a confirmé les effets physiologiques des formules de soins pour la peau ayant un potentiel émotionnel sur l'activité des neurones sensoriels de la peau humaine. CONCLUSION: Les émotions ont été affectées par le changement d'ingrédients et ont été mieux saisies par des méthodes non verbales.
Asunto(s)
Cosméticos , Piel , Humanos , Cuidados de la Piel , Epidermis , Proyectos de InvestigaciónRESUMEN
Mutations in genes encoding proteins located in the leptin/melanocortin pathway have been identified in the rare cases of genetic obesities. Heterozygous variants of MRAP2, encoding a G coupled-protein receptor accessory protein implicated in energy control notably via the melanocortin-4 receptor, have been recently identified. A 24-year-old patient with early-onset severe obesity (body mass index [BMI]: 64â kg/m2) associated with hypertension, respiratory complications, nonalcoholic fatty liver disease, and type 2 diabetes was referred to our department. Sleeve gastrectomy was successful. A new heterozygous variant in MRAP2 (NM_138409.4: c.154G>C/p.G52R) variant was identified in the patient DNA. Functional assessment confirmed that this new variant was pathogenic. We report a new pathogenic loss-of-function mutation in MRAP2 in a patient suffering from a severe multicomplicated obesity. This confirms the metabolic phenotype in patients with this monogenic form of obesity. Longer follow-up will be necessary. Our finding will allow a personalized medicine.
Asunto(s)
Cirugía Bariátrica , Diabetes Mellitus Tipo 2 , Humanos , Adulto Joven , Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas Portadoras/genética , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/cirugía , Obesidad/complicaciones , Obesidad/genética , Obesidad/cirugía , Receptor de Melanocortina Tipo 4/genética , Receptor de Melanocortina Tipo 4/metabolismoRESUMEN
Patients with obesity are known to exhibit gut microbiota dysbiosis and memory deficits. Bariatric surgery (BS) is currently the most efficient anti-obesity treatment and may improve both gut dysbiosis and cognition. However, no study has investigated association between changes of gut microbiota and cognitive function after BS. We prospectively evaluated 13 obese patients on anthropometric data, memory functions, and gut microbiota-mycobiota before and six months after BS. The Rey Auditory Verbal Learning Test (AVLT) and the symbol span (SS) of the Weschler Memory Scale were used to assess verbal and working memory, respectively. Fecal microbiota and mycobiota were longitudinally analyzed by 16S and ITS2 rRNA sequencing respectively. AVLT and SS scores were significantly improved after BS (AVLT scores: 9.7 ± 1.7 vs. 11.2 ± 1.9, p = 0.02, and SS scores: 9.7 ± 23.0 vs. 11.6 ± 2.9, p = 0.05). An increase in bacterial alpha-diversity, and Ruminococcaceae, Prevotella, Agaricus, Rhodotorula, Dipodascus, Malassezia, and Mucor were significantly associated with AVLT score improvement after BS, while an increase in Prevotella and a decrease in Clostridium, Akkermansia, Dipodascus and Candida were linked to SS scores improvement. We identified several changes in the microbial communities that differ according to the improvement of either the verbal or working memories, suggesting a complex gut-brain-axis that evolves after BS.
Asunto(s)
Cirugía Bariátrica , Microbioma Gastrointestinal , Memoria , Micobioma , Obesidad Mórbida/cirugía , Adolescente , Adulto , Anciano , Bacterias/clasificación , Bacterias/crecimiento & desarrollo , Heces/microbiología , Femenino , Hongos/crecimiento & desarrollo , Humanos , Masculino , Persona de Mediana Edad , Obesidad Mórbida/microbiología , Obesidad Mórbida/psicología , Proyectos Piloto , Estudios Prospectivos , Adulto JovenRESUMEN
The assay of multiple steroids by mass spectrometry coupled with chromatography, combined with data analysis using an artificial intelligence approach, has become more widely accessible in recent years. Multiple applications for this technology exist for the study of adrenocortical tumors. Taking advantage of the capacity of malignant cortical tumor secretion of non-bioactive precursors, it provides an additional diagnostic approach that can point to the nature of a tumor. These encouraging perspectives have been based to date only on pilot retrospective studies. However, this has changed in 2020 with the publication of data from the EURINE-ACT study. This very large prospective European study provided more nuanced evidence for the benefit of combining the measurement of a panel of steroids with essential imaging tools. This study also facilitated our understanding and provided more precise characterisation of autonomous steroid secretion, particularly in the case of sublinical cortisol-secreting adrenocortical adenomas. This article will focus on our current knowledge on the potential utility of mass spectrometry for diagnosis of both the nature of an adrenal tumors and their secretion.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/diagnóstico , Espectrometría de Masas/tendencias , Esteroides/análisis , Neoplasias de las Glándulas Suprarrenales/metabolismo , Inteligencia Artificial , Cromatografía Liquida , Técnicas de Diagnóstico Endocrino/tendencias , Humanos , Espectrometría de Masas/métodos , Oncología Médica/métodos , Oncología Médica/tendencias , Metabolómica/métodos , Metabolómica/tendencias , Esteroides/metabolismoRESUMEN
The European society of endocrinology, in association with the European network for the study of adrenal tumors, published recommendations for the diagnosis and treatment of adrenal incidentalomas in 2016. A thorough and critical analysis of the literature was performed to establish evidence-based recommendations and expert suggestions with the aim of avoiding 'over-diagnosis' and 'over-treatment' and to reduce unnecessary investigations, surgery and follow-up. The purpose of this review is to reconsider several recommendations that are open to debate, such as imaging of adrenal incidentalomas, diagnosis of pheochromocytoma, diagnosis and treatment of autonomous cortisol-secreting tumors, investigations of bilateral AI and follow-up of non-operated AIs, based on studies published after the release of the recommendations.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/terapia , Endocrinología/métodos , Endocrinología/tendencias , Neoplasias de las Glándulas Suprarrenales/diagnóstico , Neoplasias de las Glándulas Suprarrenales/patología , Diagnóstico por Imagen , Técnicas de Diagnóstico Endocrino , Humanos , Hidrocortisona/análisis , Hidrocortisona/sangre , Hallazgos Incidentales , IncertidumbreAsunto(s)
Diabetes Gestacional , Glucemia , Femenino , Edad Gestacional , Prueba de Tolerancia a la Glucosa , Humanos , EmbarazoRESUMEN
BACKGROUND: Obesity is a risk factor for chronic kidney disease (CKD) and a relative contraindication for renal transplantation. Bariatric surgery (BS) is an option to address this issue but we hypothesize that severe CKD is associated with a loss of efficacy of BS which could justify recommending it at an earlier stage of the CKD. METHODS: A retrospective study (n = 101 patients) to test primarily for differences in weight loss at 6 and 12 months according to estimated glomerular filtration rate categories (eGFR < 30 including patients on dialysis, 30-60, 60-90, and ≥ 90 ml/min/1.73 m2) was performed with multivariate analysis adjusted for sex, age, BMI, surgical procedure, and diabetes. We used a second method to confirm our hypothesis comparing weight loss in patients with stage 4-5 CKD (eGFR < 30 ml/min/1.73 m2, n = 17), and matched controls with eGFR ≥ 90 ml/min/1.73 m2. RESULTS: In the first comparison, the multivariate analysis showed a significant positive association between eGFR and weight loss. However, after exclusion of the subgroup of patients with eGFR < 30 ml/min/1.73 m2, the difference between groups was no more significant. In addition, percent total weight loss (%TWL) was significantly lower in patients with severe CKD compared to controls: - 15% vs - 23% at 6 months (p < 0.01); - 17% vs - 27% at 12 months (p < 0.01). The percent excess weight loss at 1 year reached 47% in patients with stage 4-5 CKD and 68% in controls subjects (p < 0.01). Surgery was a success at 12 months (weight loss > 50% of excess weight) in 38% of advanced CKD and 88% of controls (p < 0.01). CONCLUSION: The efficacy of BS was reduced in patients with advanced CKD. These results support early BS in patients with early-to-moderate CKD.